Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Titan Medical Inc (TMD.TO)

Titan Medical Inc (TMD.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Titan Announces the Closing of Conavi’s Private Placement of Subscription Receipts and Provides Update on the Transaction

TMDIF : 0.8175 (-6.84%)
TMD.TO : 1.1250 (-5.30%)
Stocks in play: Titan Medical Inc.

Will host a webcast Q&A session on Thursday, September 19, at 5:00 pm ET in connection with filing and ...

TMD.TO : 1.1250 (-5.30%)
Stocks in play: Titan Medical Inc.

Has entered into a licensing agreement with Auris Health, Inc., a Johnson & Johnson MedTech company, ...

TMD.TO : 1.1250 (-5.30%)
Stocks in play: Titan Medical Inc.

Announced today a corporate update and is also providing a default status report in accordance with ...

TMD.TO : 1.1250 (-5.30%)
Titan Medical Reports Financial Results for the Second Quarter 2022

New CEO Appointed, Manufacturing Progress Noted...

TMD.TO : 1.1250 (-5.30%)
TMDI : 0.1400 (-26.32%)
Titan Medical to Issue Second Quarter 2022 Financial Results on August 11, 2022

Webcast to Follow Announcement...

TMD.TO : 1.1250 (-5.30%)
TMDI : 0.1400 (-26.32%)
Titan Medical Announces Appointment of Cary G. Vance as President and Chief Executive Officer

TORONTO, June 30, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and...

TMD.TO : 1.1250 (-5.30%)
TMDI : 0.1400 (-26.32%)
Titan Medical Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

TORONTO, June 29, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and...

TMD.TO : 1.1250 (-5.30%)
TMDI : 0.1400 (-26.32%)
Stocks in play: Titan Medical Inc.

Announced that multiple disruptions have resulted in an updated Investigational Device Exemption (IDE) ...

TMD.TO : 1.1250 (-5.30%)
Titan Medical Provides Update to Enos Project Timeline

De Novo marketing authorization planned for early 2025 remains unchanged...

TMD.TO : 1.1250 (-5.30%)
TMDI : 0.1400 (-26.32%)

Barchart Exclusives

3 'Strong Buy' Cyclical Stocks to Scoop Up Now
Brokerage firm Morgan Stanley is bullish on cyclical stocks. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar